Microbot Medical Inc

MBOT Earnings — EPS History, Revenue & Growth

Reported earnings per share, revenue and net income for MBOT across recent quarters, with growth rates, margins and how those earnings translate into the multiple the market is paying today.

$1.36-4.23% todayUSD · live quote

MBOT Earnings Per Share (TTM)

$-0.26
Trailing twelve-month earnings per share reported by MBOT.
Revenue (TTM)
$19763
Net income (TTM)
$-14.21M
EPS growth
Revenue growth
-50.0%
Net margin
-2687.3%
P/E on these earnings

MBOT Quarterly EPS History

Reported earnings per share for MBOT by quarter. Consistency matters as much as size — a smooth rising series earns a higher multiple than a volatile one.

Q2 2022 EPS $-0.94Q3 2022 EPS $-0.06Q4 2022 EPS $0.00Q2 2023 EPS $0.00Q3 2023 EPS $0.00Q4 2023 EPS $-1.00Q1 2024 EPS $0.00Q2 2024 EPS $0.00Q3 2024 EPS $0.00Q4 2024 EPS $0.00Q1 2025 EPS $0.00Q2 2025 EPS $0.00Q3 2025 EPS $0.00Q4 2025 EPS $0.00Q1 2026 EPS $0.00

MBOT Revenue by Quarter

Top-line revenue for MBOT. Earnings growth that outpaces revenue growth comes from margin expansion, which is finite; revenue growth is the durable driver.

Q2 2011 revenue $455564Q2 2013 revenue $110333Q3 2013 revenue $324792Q1 2014 revenue $339480Q2 2014 revenue $242204Q3 2014 revenue $269664Q1 2015 revenue $20997Q3 2015 revenue $67161Q4 2015 revenue $28729Q1 2016 revenue $23164Q2 2016 revenue $29311Q3 2016 revenue $32762Q1 2026 revenue $19763

MBOT Earnings Results by Period

The last 12 reported periods for MBOT, most recent first.

PeriodEPSRevenueNet incomeNet margin
Q1 2026$0.00$19763$-3.67M-18575.1%
Q4 2025$0.00$-3.46M
Q3 2025$0.00$-3.58M
Q2 2025$0.00$-3.50M
Q1 2025$0.00$-2.60M
Q4 2024$0.00$-3.39M
Q3 2024$0.00$-3.21M
Q2 2024$0.00$-2.46M
Q1 2024$0.00$-2.37M
Q4 2023$-1.00$-3.15M
Q3 2023$0.00$-2.45M
Q2 2023$0.00$-5.14M

Earnings vs Valuation & Market Positioning

Earnings set the base; the multiple and the statistical stretch of the price decide what you actually pay.

Market cap
$91.34M
Trailing P/E
Forward P/E
Gross margin
-185.3%
1H
-0.47
Statistically neutral
4H
-0.63
Statistically neutral
1D
-0.74
Statistically neutral

How This MBOT Earnings Data Is Built

Quarterly EPS, revenue and net income are pulled from MBOT's reported filings through live ZCoreAI market endpoints. Trailing twelve-month figures sum the last four reported quarters. Net margin per period is net income divided by revenue for that same period, and year-over-year comparisons use the quarter four periods back to avoid seasonality distortions.

Growth rates come from the same reported series rather than adjusted or non-GAAP management figures, so they can differ from headline numbers quoted in company presentations. Nothing on this page is investment advice.

MBOT Earnings FAQ

What are MBOT earnings per share?

MBOT reported trailing twelve-month EPS of $-0.26, the sum of the last four reported quarters divided across shares outstanding.

Are MBOT earnings growing?

A growth rate for MBOT is not available from the latest reported figures.

When does MBOT report earnings?

MBOT reports on a quarterly cycle. The table above shows the most recent reported periods; the next release typically follows roughly three months after the latest period shown.

How do MBOT earnings affect the stock price?

Price equals earnings times the multiple. every dollar of EPS added or lost is amplified by that multiple, which is why earnings surprises move the price far more than the size of the surprise alone.

Where does ZCoreAI get MBOT earnings data?

Reported EPS, revenue, net income and margins come from live ZCoreAI market endpoints sourced from company filings, refreshed on every page load.

MBOT financials

Income statement, margins, cash and debt for MBOT.

MBOT P/E ratio

Trailing and forward multiples, PEG and earnings yield for MBOT.

MBOT forecast

DCF fair value, price prediction and signal targets for MBOT.

MBOT overview

Live chart, fundamentals and valuation context for MBOT.

MBOT dividends

Payout history, yield and dividend growth for MBOT.

Data refreshed from live ZCoreAI market endpoints. Informational only — not investment advice.